High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the meantime, a market for cheaper, compounded drugs thrives.

Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price tags of over $1,000 a month.

Injectable weight loss drugs are popular right now but can be hard to get because they are in short supply or too expensive without insurance. The result is that some people are skipping the doctor's office and reaching out to potentially unreliable sources such as unlicensed online pharmacies or telehealth sites,

Cost (18 per cent) is the major reason identified in the survey, followed by not being covered by insurance (15 per cent), inability to get a prescription

A new study from The Ohio State University’s Wexner Medical Center found that 25% of U.S. adults would consider using prescription weight loss medications without consulting a doctor first. Veuer’s Chloe Hurst has the story!